Beta Drugs P/B Ratio
Beta Drugs P/B ratio. Beta Drugs (BETA) P/B ratio is 9.32 (High), book value per share ₹245.00 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse Beta Drugs shareholding analysis to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
BETA P/B Ratio — Valuation Insights & Book Value Analysis
Beta Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 9.32 (High). For live price, earnings yield and the full fundamental profile, see BETA screener.
- Stock appears overvalued with PB of 9.32, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of 0.01
Beta Drugs P/B Ratio Historical Trend
BETA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View BETA price range for the annual high/low range and current price position.
BETA Historical P/B Ratio — Book Value Per Share & Year-End Price
Beta Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 8.18 | ₹245.0 | ₹2004.00 | ₹245 | High |
| 2025 | 7.86 | ₹197.0 | ₹1549.10 | ₹197 | High |
BETA vs Healthcare Peers — P/B Ratio Comparison
Beta Drugs P/B 9.32 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |